Roles of the m6A Modification of RNA in the Glioblastoma Microenvironment as Revealed by Single-Cell Analyses

Abstract

PurposeGlioblastoma multiforme (GBM) is a common and aggressive form of brain tumor. The N6-methyladenosine (m6A) mRNA modification plays multiple roles in many biological processes and disease states. However, the relationship between m6A modifications and the tumor microenvironment in GBM remains unclear, especially at the single-cell level.Experimental DesignSingle-cell and bulk RNA-sequencing data were acquired from the GEO and TCGA databases, respectively. We used bioinformatics and statistical tools to analyze associations between m6A regulators and multiple factors.ResultsHNRNPA2B1 and HNRNPC were extensively expressed in the GBM microenvironment. m6A regulators promoted the stemness state in GBM cancer cells. Immune-related BP terms were enriched in modules of m6A-related genes. Cell communication analysis identified genes in the GALECTIN signaling network in GBM samples, and expression of these genes (LGALS9, CD44, CD45, and HAVCR2) correlated with that of m6A regulators. Validation experiments revealed that MDK in MK signaling network promoted migration and immunosuppressive polarization of macrophage. Expression of m6A regulators correlated with ICPs in GBM cancer cells, M2 macrophages and T/NK cells. Bulk RNA-seq analysis identified two expression patterns (low m6A/high ICP and high m6A/low ICP) with different predicted immune infiltration and responses to ICP inhibitors. A predictive nomogram model to distinguish these 2 clusters was constructed and validated with excellent performance.ConclusionAt the single-cell level, m6A modification facilitates the stemness state in GBM cancer cells and promotes an immunosuppressive microenvironment through ICPs and the GALECTIN signaling pathway network. And we also identified two m6A-ICP expression patterns. These findings could lead to novel treatment strategies for GBM patients.

ptx3a+ fibroblast/epicardial cells provide a transient macrophage niche to promote heart regeneration

“…To explore the molecular mechanisms underlying the dialogue established between Fb/Epi cells and macrophages, we analyzed the significant ligand-receptor pairs of the signals from Fb/Epi cells to macrophages. We identified 5 primary signaling pathways in both zebrafish ( Figure 5A ) and neonatal mice Fb/Epi cells ( Figure 5B ), among which 4 signaling molecules are associated with reparative macrophages, including Csf1 , 57 , 58 Cxcl12 , 59 Angptl4 , 60 and Mdk 61 pathways. In macrophages, we identified expression of Csf1r , 57 Sdc4 , 62 , 63 and Cxcr4 64 as the primary receptors of these signals.…”

Prognosis and immunoinfiltration analysis of angiogene-related genes in grade 4 diffuse gliomas

“…Recent studies reported prognostic significance in diffuse glioma for ITGA3 and MAP1LC3A, two autophagy-related genes [13], BCL7A, a protein involved in ATP-dependent chromatin remodeling [17], and lipid metabolism genes [18]. More recently, Yuan et al established a positive association between M 6 A methylation status and glioblastoma stemness, immune checkpoint expression, and promotion of an immunosuppressive environment [19]. Our current study, which focused exclusively on grade 4 diffuse www.aging-us.com 9850 AGING gliomas, the most aggressive primary brain tumors, revealed that a nomogram based on COL22A1, IGFBP2, and MPO expression can reliably evaluate patient prognosis.…”

m6A methylation regulators as predictors for treatment of advanced urothelial carcinoma with anti-PDL1 agent

“…Some studies have shown that HNRNPA2B1 can promote tumor immunity and anti-tumor. For example, there is a significant positive correlation between HNRNPA2B1 and M1 macrophages in esophageal cancer ( 39 ), and the expression of HNRNPA2B1 is higher in M1 macrophages and T/NK cells than in other cells in glioblastoma ( 53 ). In contrast, other studies have revealed that HNRNPA2B1 inhibits tumor immunity.…”